For patients with diabetes, more frequent blood glucose monitoring or continuous glucose monitoring (CGM) is recommended if you suspect your medication has been compromised
Current clinical research suggests that retatrutide may produce greater average weight loss than semaglutide
and statements regarding expanded access to treatment options on our platform
Each patient may lose weight at a different rate and experience different side effects
Multiple companies, including Lilly, Pfizer, Amgen, Structure Therapeutics, and Viking Therapeutics, are competing to develop the next breakthrough obesity drug
Demand for weight loss drugs has soared over the last year, to the point that semaglutide better known by the brand names Ozempic and Wegovy has been in short supply at pharmacies nationwide